Primary Record
Sunitinib malate
- In stock
- 9,466 g
- Purity
- 98.7 %
- CAS
- 341031-54-7
Compound Identifiers & Properties
- CAS
- 341031-54-7
- PubChem CID
- 6456015
- SMILES
- CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C.C([C@@H](C(=O)O)O)C(=O)O
- Canonical SMILES
- CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C.O=C(O)C[C@H](O)C(=O)O
Names & Synonyms
- Sunitinib malate
- Sutent
- 341031-54-7
- Sunitinib
- sunitinib L-malate
- Sutent;
- Sunitinib (Malate)
- SU011248 L-malate salt
- Sunitinib malate [USAN]
- PDGF TK antagonist
- Sutent (TN)
- SUNITINIB MALEATE
- PHA-290940AD
- LVX8N1UT73
- SU-011248 L-malate salt
- RefChem:56081
- UNII-LVX8N1UT73
- AC1O5CMQ
- Sutent (TN) (Pfizer)
- DTXSID4046492
- MFCD08282795
- Sunitinib Malate (Sutent)
- (-)-malic acid; sunitinib
- SU010398
- CHEMBL1567
- C26H33FN4O7
- SU-11248 L-malate salt
- SUNITINIB MALATE [MI]
- Sunitinib malate (JAN/USAN)
- LBWFXVZLPYTWQI-IPOVEDGCSA-N
- SUNITINIB MALATE [JAN]
- DTXCID801476195
- orb1310676
- SCHEMBL1258610
- Sunitinib (Malate) (Standard)
- SCHEMBL29371243
- SU-11248
- SUNITINIB MALATE [VANDF]
- AOB5508
- QCR-103
- SU-010398
- SUNITINIB MALATE [MART.]
- CHEBI:232546
- NSC736511
- PNU-290940AD
- SUNITINIB MALATE [WHO-DD]
- HMS3261H09
- HMS6018J17
- SU011248
- SU 011248
- Sunitinib malate, >=98% (HPLC)
- Tox21_112249
- Tox21_500514
- AN-777
- HY-10255R
- NP3249
- s1042
- SU-11248J
- Sunitinib malate - Bio-X trade mark
- SU 11248
- AKOS005145765
- AKOS025149097
- Sunitinib Malate (Sunitinib L-Malate)
- SUNITINIB MALATE [ORANGE BOOK]
- Tox21_112249_1
- ACN-031544
- CCG-221818
- CID6456015
- CS-0177
- CS-O-11751
- EBC-218028
- FS10822
- KS-5023
- NSC-736511
- RL03260
- Su-011248
- Sunitinib malate, 98% - 10MG 10mg
- NCGC00164631-01
- NCGC00164631-05
- NCGC00261199-01
- AT-15587
- BP-43644
- BS164428
- HY-10255
- MS-33338
- SU-12662
- SY075040
- AB0020988
- LS-186078
- SU-11248;
- TL8002546
- AM20090634
- CAS-341031-54-7
- SW219407-1
- V2095
- (Z)-N-(2-(diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (S)-2-hydroxysuccinate
- C22-H27-F-N4-O2.C4-H6-O5
- A10880
- D06402
- X-1524
- 031S547
- A822079
- Q27283213
- N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide;(2S)-2-hydroxybutanedioic acid
- (2S)-2-hydroxybutanedioic acid; N-[2-(diethylamino)ethyl]-5-{[(3Z)-5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-2,4-dimethyl-1H-pyrrole-3-carboxamide
- Butanedioic acid, hydroxy-, (2S)-, compd. with N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1)
- 1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-, (2S)-hydroxybutanedioate (1:1)
- Butanedioic acid, 2-hydroxy-, (2S)-, compd. with N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1)
- N-(2- -5-( - -2,4-dimethyl-1H-pyrrole-3-carboxamide -hydroxybutanedioate
- N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-hydroxybutanedioate
- (2S)-2-Hydroxybutanedioic acid compd. with N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1)
- (2S)-2-Hydroxybutanedioic acid--N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (1/1)
- (Z)-N-(2-(diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide(S)-2-hydroxysuccinate
- 1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-, (2S)-hydroxybutanedioate (1:1)
- 1H-Pyrrole-3-carboxamide, N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-, (2S)-hydroxybutanedioate (1:1)
- 1H-Pyrrole-3-carboxamide,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-, (2S)-hydroxybutanedioate (1:1)
- 1H-Pyrrole-3-carboxamide,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-, malate salt
- Butanedioic acid, (2S)-, compd. with N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1)
- Butanedioic acid, (2S)-, compd. with N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1) (CA INDEX NAME)
- Butanedioic acid, hydroxy-, (2S)-, compd. with N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1)
- Butanedioic acid,2-hydroxy-,(2S)-,compd. with N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1)
- N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; (2S)-2-hydroxybutanedioic acid
- N-[2-(Diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide Malate
- N-[2-(Diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidine)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-2-hydroxybutanedioate salt
- N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-indolin-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; (2S)-2-hydroxybutanedioic acid
- N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-indolin-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide;(2S)-2-hydroxybutanedioic acid